Cabinet Secretary Karlo Nograles assured that PhilHealth will continue to cover treatment costs for all COVID-19 patients, despite ongoing issues with the agency.
PhilHealth clarified that the suspension of its Interim Reimbursement Mechanism (IRM) program will not affect the availment of COVID-19 benefits or any of its regular benefits by its members.
The IRM suspension is intended to allow for a review in light of recent Senate and congressional hearings.
PhilHealth reaffirmed the legality and necessity of the IRM in the country's overall COVID-19 response and dismissed allegations of 'favoritism' in its disbursement.
The agency vowed to continue working with legislators and investigating bodies to address their concerns.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.



